Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06893302 · ClinicalTrials.gov registry record · NA

Impact of Bone-Marrow Aspirate Injections in Knee Arthroscopy

A NA study of Osteoarthritis (OA) of the Knee and Cartilage Defects of the Knee, sponsored by Hospital for Special Surgery, New York.

Recruiting
Registry status
NA
Development phase
50
Enrollment target
1
Study location

NCT06893302: Recruiting NA study of Osteoarthritis (OA) of the Knee and Cartilage Defects of the Knee, sponsored by Hospital for Special Surgery, New York.

NCT06893302 is a NA study of Osteoarthritis (OA) of the Knee and Cartilage Defects of the Knee that is actively recruiting participants, run by Hospital for Special Surgery, New York. The registered enrollment target is 50 participants, below the 1,407-participant average among 8 other Osteoarthritis (OA) of the Knee trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06893302, a NA study of Osteoarthritis (OA) of the Knee and Cartilage Defects of the Knee, is actively recruiting participants, sponsored by Hospital for Special Surgery, New York.

RECRUITING
Registry status
NA
Development phase
50 participants
Enrollment target
1
Study location

Study Summary

This study will examine whether using bone marrow aspirate (BMA) during knee arthroscopy surgery can improve patient outcomes. The investigators will enroll 50 patients who need knee arthroscopy surgery for meniscus injuries or cartilage damage. Like flipping a coin, patients will be randomly assigned to one of two groups of 25 patients each. One group will receive standard arthroscopic surgery plus an injection of bone marrow aspirate, while the other group will receive standard surgery plus a saline (salt water) injection. During surgery, for patients in the treatment group, approximately 4mL (less than one teaspoon) of bone marrow will be taken from their hip bone using a special needle system. A small amount (1mL) will be sent to the laboratory for testing. Patients will be followed for 12 months after surgery and will complete questionnaires about their pain levels and knee function at several time points: before surgery, 2 weeks, 6 weeks, 3 months, 6 months, and 12 months after surgery. These questionnaires will ask about pain, daily activities, and overall improvement.

Primary Outcome

Knee Injury and Osteoarthritis Outcomes Score (KOOS) 0-100 score range, with 0 representing extreme knee problems and 100 representing no knee problems.

Interventions

  • OTHER Saline
  • BIOLOGICAL Bone Marrow Aspirate (BMA)
  • PROCEDURE Arthroscopic Debridement Surgery

Study Locations (1)

New York

  • Hospital for Special Surgery - New York

Trial Details

FieldValue
Enrollment Target 50 participants
Start Date 2026-06
Est. Completion 2029-04
Phase NA

What NCT06893302 shows while recruiting

NCT06893302 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 50 participants, a relatively small participant target, below the 1,407-participant average among 8 other Osteoarthritis (OA) of the Knee trials with a reported enrollment target (96% lower).

The record links to 4 conditions, with Osteoarthritis (OA) of the Knee appearing as the primary indexed condition, and to 3 interventions - of which Saline is the first listed.

NCT06893302 reports a single indexed study location in New York.

Frequently Asked Questions

What is clinical trial NCT06893302 about?

NCT06893302 is a clinical study titled "Impact of Bone-Marrow Aspirate Injections in Knee Arthroscopy". This study will examine whether using bone marrow aspirate (BMA) during knee arthroscopy surgery can improve patient outcomes. The investigators will enroll 50 patients who need knee arthroscopy surgery for meniscus injuries or cartilage damage. Like flipping a coin, patients will be randomly assign...

What is the current status of trial NCT06893302?

This trial is currently recruiting. It is a NA study. The enrollment target is 50 participants. The study started on 2026-06. Estimated completion is 2029-04.

What conditions does trial NCT06893302 study?

This clinical trial studies the following conditions: Osteoarthritis (OA) of the Knee, Cartilage Defects of the Knee, Chondral Lesion of the Knee, Meniscal Injuries.

What interventions are being tested in trial NCT06893302?

The interventions under investigation include: Saline (OTHER), Bone Marrow Aspirate (BMA) (BIOLOGICAL), Arthroscopic Debridement Surgery (PROCEDURE).

Who is sponsoring clinical trial NCT06893302?

This trial is sponsored by Hospital for Special Surgery, New York, which has 194 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06893302 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Osteoarthritis (OA) of the Knee

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06893302's enrollment target sits among peer trials

50 9th of 8 the lowest of 8 other Osteoarthritis (OA) of the Knee trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Osteoarthritis (OA) of the Knee trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00200889 · 50 participants · Early Phase 1

    Mapping Auricular Vagus Nerve Circuitry

  • NCT00409435 · 50 participants · Phase 2

    A Study of Pyridostigmine in Postural Tachycardia Syndrome

  • NCT01202305 · 50 participants

    The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies

  • NCT01225913 · 50 participants · Phase 4

    Mechanism(s) of Airflow Limitation During Exacerbation of Asthma

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT06893302, the US trial registry maintained by the National Library of Medicine. NCT06893302 (small enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.